Format

Send to

Choose Destination
Cancer Cytopathol. 2019 Apr 24. doi: 10.1002/cncy.22132. [Epub ahead of print]

Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.

Author information

1
Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.
2
Department of Radiology, The Johns Hopkins Hospital, Baltimore, Maryland.
3
Department of Endocrine Surgery, Cleveland Clinic, Cleveland, Ohio.
4
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
5
Department of Medicine, Florida International University, Memorial Healthcare System, Hollywood, Florida.
6
Department of Clinical Affairs, Veracyte Inc, South San Francisco, California.
7
Department of Medical Affairs, Veracyte Inc, South San Francisco, California.
8
Department of Research and Development, Veracyte Inc, South San Francisco, California.
9
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

KEYWORDS:

clinical validation; indeterminate cytology; machine learning; molecular diagnostics; thyroid nodule

PMID:
31017745
DOI:
10.1002/cncy.22132

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center